立体定向放疗治疗脑转移瘤患者的免疫治疗和症状性放射性坏死。
Immunotherapy and Symptomatic Radiation Necrosis in Patients With Brain Metastases Treated With Stereotactic Radiation.
机构信息
Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts.
Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
出版信息
JAMA Oncol. 2018 Aug 1;4(8):1123-1124. doi: 10.1001/jamaoncol.2017.3993.
Abstract
This study investigates the association between immunotherapy and symptomatic radiation necrosis in patients with melanoma, non–small-cell lung cancer, or renal cell carcinoma and newly diagnosed brain metastases treated with stereotactic radiation therapy.
摘要
本研究调查了立体定向放射治疗治疗的伴有新诊断脑转移的黑色素瘤、非小细胞肺癌或肾细胞癌患者免疫治疗与症状性放射性坏死之间的关系。
相似文献
1
Immunotherapy and Symptomatic Radiation Necrosis in Patients With Brain Metastases Treated With Stereotactic Radiation.立体定向放疗治疗脑转移瘤患者的免疫治疗和症状性放射性坏死。
JAMA Oncol. 2018 Aug 1;4(8):1123-1124. doi: 10.1001/jamaoncol.2017.3993.
2
Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.同步免疫检查点抑制剂和立体定向放射外科治疗非小细胞肺癌、黑色素瘤和肾细胞癌的脑转移。
Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):916-925. doi: 10.1016/j.ijrobp.2017.11.041. Epub 2017 Dec 5.
3
Symptomatic radiation necrosis in brain metastasis patients treated with stereotactic radiosurgery and immunotherapy.接受立体定向放射外科和免疫治疗的脑转移瘤患者的症状性放射性坏死
Clin Neurol Neurosurg. 2019 Apr;179:14-18. doi: 10.1016/j.clineuro.2019.02.010. Epub 2019 Feb 11.
4
Toxicity and efficacy of Gamma Knife radiosurgery for brain metastases in melanoma patients treated with immunotherapy or targeted therapy-A retrospective cohort study.免疫治疗或靶向治疗的黑色素瘤脑转移患者行伽玛刀放射外科治疗的毒性和疗效：一项回顾性队列研究。
Cancer Med. 2020 Jun;9(11):4026-4036. doi: 10.1002/cam4.3021. Epub 2020 Apr 6.
5
Multidose stereotactic radiosurgery (9 Gy × 3) of the postoperative resection cavity for treatment of large brain metastases.术后切除腔的多次立体定向放射外科治疗（9 Gy×3）用于治疗大型脑转移瘤。
Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):623-9. doi: 10.1016/j.ijrobp.2013.03.037. Epub 2013 May 15.
6
[Immuno-Oncology therapeutic principles in lung and renal cell carcinoma].[肺癌和肾细胞癌的免疫肿瘤治疗原则]
Oncol Res Treat. 2014;37 Suppl 4:10-3. doi: 10.1159/000366433. Epub 2014 Sep 30.
7
Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery.免疫检查点疗法的时机和类型会影响黑色素瘤脑转移瘤对立体定向放射外科治疗的早期影像学反应。
Cancer. 2016 Oct;122(19):3051-8. doi: 10.1002/cncr.30138. Epub 2016 Jun 10.
8
The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases: the potential impact of immunotherapy.黑色素瘤脑转移立体定向放射治疗后放射性坏死的发生率：免疫治疗的潜在影响。
Anticancer Drugs. 2017 Jul;28(6):669-675. doi: 10.1097/CAD.0000000000000497.
9
Multicenter Evaluation of the Tolerability of Combined Treatment With PD-1 and CTLA-4 Immune Checkpoint Inhibitors and Palliative Radiation Therapy.PD-1与CTLA-4免疫检查点抑制剂联合治疗及姑息性放射治疗耐受性的多中心评估
Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):344-351. doi: 10.1016/j.ijrobp.2017.02.003. Epub 2017 Feb 11.
10
Toxicity and time lapse between immunotherapy and stereotactic radiotherapy of brain metastases.脑转移瘤免疫治疗与立体定向放疗的毒性和时间延迟。
Cancer Radiother. 2021 Jul;25(5):432-440. doi: 10.1016/j.canrad.2021.01.007. Epub 2021 Apr 6.
引用本文的文献
1
Survival benefits of concurrent immune checkpoint inhibitor and radiotherapy in non-small cell lung cancer with brain metastases.免疫检查点抑制剂与放疗联合用于非小细胞肺癌脑转移患者的生存获益
World J Clin Oncol. 2025 Aug 24;16(8):107009. doi: 10.5306/wjco.v16.i8.107009.
2
Efficacy of Radiotherapy for Oligometastatic Lung Cancer and Irradiation Methods Based on Metastatic Site.基于转移部位的寡转移肺癌放疗疗效及照射方法
Cancers (Basel). 2025 Aug 4;17(15):2569. doi: 10.3390/cancers17152569.
3
Impact of stereotactic radiosurgery timing relative to immune checkpoint blockade administration on brain metastasis disease and radionecrosis outcomes.立体定向放射外科治疗时机相对于免疫检查点阻断剂给药对脑转移瘤疾病和放射性坏死结局的影响。
Neurooncol Adv. 2025 Jun 18;7(1):vdaf130. doi: 10.1093/noajnl/vdaf130. eCollection 2025 Jan-Dec.
4
Management outcomes for biopsy-proven radiation necrosis in patients with brain metastases in the era of immune-checkpoint blockade.免疫检查点阻断时代脑转移瘤患者经活检证实的放射性坏死的管理结果
J Neurooncol. 2025 Jun 16. doi: 10.1007/s11060-025-05120-y.
5
Focusing attention on brain metastasis: Hot issues.聚焦脑转移瘤：热点问题
Neurooncol Pract. 2025 Mar 1;12(3):353-354. doi: 10.1093/nop/npaf025. eCollection 2025 Jun.
6
Seizure risk factors and management approaches in patients with brain metastases.脑转移瘤患者的癫痫发作风险因素及管理方法。
Neurooncol Pract. 2025 Jan 13;12(3):389-400. doi: 10.1093/nop/npaf001. eCollection 2025 Jun.
7
Development of a recursive partitioning analysis for prediction of radiation necrosis following single-fraction stereotactic radiosurgery for intact brain metastases.用于预测完整脑转移瘤单次立体定向放射外科治疗后放射性坏死的递归划分分析的开发。
J Neurooncol. 2025 Sep;174(2):503-510. doi: 10.1007/s11060-025-05062-5. Epub 2025 May 13.
8
Local recurrence and radionecrosis after single-isocenter multiple targets stereotactic radiotherapy for brain metastases.脑转移瘤单中心多靶点立体定向放射治疗后的局部复发和放射性坏死
Sci Rep. 2025 May 5;15(1):15722. doi: 10.1038/s41598-025-01034-x.
9
Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase Ib study.纳武利尤单抗与立体定向放射外科治疗乳腺癌脑转移患者：一项非随机、开放标签的Ib期研究的长期结果及生物标志物分析
J Immunother Cancer. 2025 Apr 28;13(4):e011432. doi: 10.1136/jitc-2024-011432.
10
Immunotherapy may promote the occurrence of radiation-induced brain injury in NSCLC patients with brain metastases undergoing radiotherapy: a retrospective propensity score-matching and inverse probability of treatment weighting study.免疫疗法可能会促进接受放疗的非小细胞肺癌脑转移患者发生放射性脑损伤：一项回顾性倾向评分匹配和治疗权重逆概率研究。
Clin Transl Oncol. 2025 Apr 27. doi: 10.1007/s12094-025-03928-8.
本文引用的文献
1
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.帕博利珠单抗用于治疗黑色素瘤或非小细胞肺癌且伴有未经治疗的脑转移患者：一项非随机、开放标签的2期试验的早期分析
Lancet Oncol. 2016 Jul;17(7):976-983. doi: 10.1016/S1470-2045(16)30053-5. Epub 2016 Jun 3.
2
Single-center study under a French Temporary Authorization for Use (TAU) protocol for ipilimumab in metastatic melanoma: negative impact of baseline corticosteroids.一项在法国临时使用授权（TAU）方案下开展的关于伊匹木单抗治疗转移性黑色素瘤的单中心研究：基线皮质类固醇的负面影响
Eur J Dermatol. 2015 Jan-Feb;25(1):36-44. doi: 10.1684/ejd.2014.2471.
3
Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial.伊匹单抗治疗黑色素瘤伴脑转移患者的开放性 2 期试验。
Lancet Oncol. 2012 May;13(5):459-65. doi: 10.1016/S1470-2045(12)70090-6. Epub 2012 Mar 27.
4
Cerebral radiation necrosis.脑放射性坏死
Neurologist. 2003 Jul;9(4):180-8. doi: 10.1097/01.nrl.0000080951.78533.c4.
Zotero 插件